Glaukos

GKOS NYSE
75.14
-1.10
-1.44%
Closed 17:04 07/19 EDT
Open
76.51
Prev Close
76.24
High
77.22
Low
75.13
Volume
188.20K
Avg Vol (3M)
361.90K
52 Week High
83.14
52 Week Low
36.89
% Turnover
0.52%
Market Cap
2.74B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Glaukos GKOS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm's canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream. It is developing three additional pipeline products: the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is a drug delivery system that is designed to be implanted in the eye to continuously deliver therapeutic levels of medication for extended periods of time to lower intraocular pressure in glaucoma patients.
MORE >

Recently

Name
Price
%Change